Changeflow GovPing Pharma & Drug Safety Patent Application: Complex for Cartilage Diffe...
Routine Notice Added Draft

Patent Application: Complex for Cartilage Differentiation

Favicon for changeflow.com ChangeBridge: Patent Apps - Biotech (C12N)
Published June 2nd, 2025
Detected March 27th, 2026
Email

Summary

The USPTO has published a new patent application (US20260083780A1) detailing a complex for promoting cartilage differentiation. The application describes a method for fabricating cartilage and a pharmaceutical composition for treating arthropathy, filed on June 2, 2025.

What changed

This document is a publication of a new patent application filed with the USPTO, specifically application number US20260083780A1. The application, titled 'Complex for promoting cartilage differentiation comprising stem cells or a culture thereof and a cartilage cell-free crush, and use thereof,' was filed on June 2, 2025. It describes a complex intended to promote cartilage differentiation, a method for fabricating cartilage using this complex, and a pharmaceutical composition for preventing or treating arthropathy.

As this is a patent application, it does not impose immediate regulatory obligations or compliance deadlines on regulated entities. However, it signals potential future developments in the biotechnology and healthcare sectors related to cartilage regeneration and arthropathy treatment. Companies operating in these areas may wish to monitor the progress of this patent application and related intellectual property.

Source document (simplified)

← USPTO Patent Applications

COMPLEX FOR PROMOTING CARTILAGE DIFFERENTIATION COMPRISING CARTILAGE CELL-FREE CRUSH AND STEM CELL AND USE THEREOF

Application US20260083780A1 Kind: A1 Mar 26, 2026

Inventors

Kyung Sun Kang, Seung Hee Lee, Jong Chan Ahn, Mi Jin Kim

Abstract

The present invention relates to a complex for promoting cartilage differentiation comprising stem cells or a culture thereof and a cartilage cell-free crush, a method for fabricating cartilage by using the complex, cartilage fabricated via the method, a pharmaceutical composition comprising the complex for preventing or treating arthropathy, a method for preventing or treating arthropathy using the composition, a composition for inducing cartilage cell differentiation comprising the prepared cartilage cells, and a method for fabricating cartilage using the prepared cartilage cells. The complex for promoting cartilage differentiation comprising the stem cells or the culture thereof and the cartilage cell-free crush provided in the present invention is not only differentiated into cartilage cells without side effects even in vivo, but also promotes differentiation of inherent stem cells in vivo into cartilage cells via a paracrine effect exhibited in the differentiated cartilage cells to effectively regenerate the damaged cartilage, and thus the complex may be widely used for treatment of arthropathy involving the cartilage damage.

CPC Classifications

A61K 35/32 A61K 35/51 A61K 35/545 C12N 5/0655 C12N 5/0665 C12N 2506/1369

Filing Date

2025-06-02

Application No.

19225491

View original document →

Classification

Agency
USPTO
Published
June 2nd, 2025
Instrument
Notice
Legal weight
Non-binding
Stage
Draft
Change scope
Minor
Document ID
US20260083780A1

Who this affects

Applies to
Drug manufacturers Medical device makers Healthcare providers
Industry sector
3254 Pharmaceutical Manufacturing 3345 Medical Device Manufacturing 6211 Healthcare Providers
Activity scope
Drug Labeling Medical Device Manufacturing
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Legal
Compliance frameworks
FDA 21 CFR Part 11 GxP
Topics
Pharmaceuticals Medical Devices

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Apps - Biotech (C12N) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.